Oculis Holding AG (OCS) Other Non-Current Assets (2022 - 2026)

Oculis Holding AG (OCS) recorded quarterly Other Non-Current Assets of $1.0 million in Q1 2026, up 3.5% quarter-over-quarter from $982168.3 in Q4 2025, and up 79.9% on a YoY basis from $565023.3 in Q1 2025.

Oculis Holding AG (OCS) Other Non-Current Assets (2022 - 2026) Analysis & Trends

Oculis Holding AG's Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $1.0 million for Q1 2026.

  • In Q1 2026, Other Non-Current Assets rose 79.9% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (up 79.9% YoY), while the FY2025 annual figure was $982168.3, up 80.76% from the prior year.
  • Other Non-Current Assets was $1.0 million for Q1 2026 at Oculis Holding AG, up from $982168.3 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.0 million in Q1 2026 to a low of $76813.6 in Q4 2022.
  • Historically, Other Non-Current Assets has averaged $411139.4 across 5 years, with a median of $196831.2 in 2024.
  • The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets climbed 25.66% in 2024, then soared 466.87% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $76813.6 in 2022, then jumped by 30.62% to $100334.5 in 2023, then surged by 441.55% to $543364.4 in 2024, then soared by 80.76% to $982168.3 in 2025, then increased by 3.5% to $1.0 million in 2026.
  • The last three Other Non-Current Assets figures came in at $1.0 million (Q1 2026), $982168.3 (Q4 2025), and $665058.3 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 60,000.00
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 1.26 Bn
9 Abivax 90.15 Bn 90.15 Bn - -
10 Oculis Holding AG 8.23 Bn 7.92 Bn - 1.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.02 Mn
Dec 31, 2025 982,168.29
Sep 30, 2025 665,058.26
Jun 30, 2025 643,805.49
Mar 31, 2025 565,023.27
Dec 31, 2024 543,364.40
Sep 30, 2024 183,518.95
Jun 30, 2024 196,831.24
Mar 31, 2024 99,674.36
Dec 31, 2023 100,334.55
Sep 30, 2023 146,047.68
Jun 30, 2023 125,675.84
Dec 31, 2022 76,813.62